In light of the above observations that activation of NF-κB signaling is associated with lung cancer malignancy, we further confirmed the phosphorylation levels of MARCKS and p65 (S536), an indicator of the activated form of NF-κB, in lung cancer specimens by performing IHC staining. This evidence concerns the gene MARCKS and lung cancer.